Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.47 -0.14 (-0.55%) Market Cap: 40.55 Bil Enterprise Value: 65.84 Bil PE Ratio: 23.04 PB Ratio: 0.96 GF Score: 82/100

Q2 2022 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

Oct 28, 2021 / 09:30AM GMT
Release Date Price: €24.68 (+1.56%)
Christopher David O;Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance

' -

Thank you very much for your participation in this FY 2021 Second Quarter Earnings Conference Call. I am (inaudible), the Global Head of IR. I'd like to serve as a moderator today. And well, first, I would like to explain about language settings.

In the lower right corner of the Zoom, there is a setting bottom group sign. Click on it and select Japanese if you want to listen in Japanese and click English if you want to listen in English. If you would like to listen original voice in English with Japanese without the interpretation, please (technical difficulty).

Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in the most recent Form 20-F and in our other SEC filings. Please also refer to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot